Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks.
Target Price
The average target price of ABSI is 7.5 and suggests 147% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell